Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
p73, a homologue to the tumor suppressor gene
p53
, is involved in tumorigenesis, though its specific role remains unclear. The gene has two distinct promoters which allow the formation of two protein isoforms with opposite effects: full-length transactivating (TA) p73 shows pro-apoptotic effects, while the shorter DeltaNp73, which lacks the N-terminal transactivating domain, has an evident anti-apoptotic function. Unlike
p53
, the p73 gene is rarely mutated in human cancers. However, alterations in the relative levels of TA and DeltaNp73 have been shown to correlate with prognosis in several human cancers, suggesting that the fine regulation of these two isoforms is of pivotal importance in controlling proliferation and cell death. Much effort is currently focused on the elucidation of the mechanisms that differentially control TA and DeltaNp73 activity and protein stability, a process complicated by the finding that both proteins are regulated by a similar suite of complex post-translational modifications that include ubiquitination, sequential phosphorylation, prolyl-isomerization, recruitment into the PML-nuclear body (PML-NB), and acetylation. Here we shall consider the main regulatory partners of p73, with particular attention to the recently discovered Itch- and Nedd8-mediated degradation pathways, along with the emerging roles of PML, p38 MAP kinase,
Pin1
, and p300 in p73 transcriptional activation, and possible mechanisms for the differential regulation of the TAp73 and DeltaNp73 isoforms.
...
PMID:Regulation of the p73 protein stability and degradation. 1586 26
Peptidyl-proline isomerase (
Pin1
) is able to trigger some conformationally important change in the
p53 protein
: there is notable protection by
p53
(tumour suppressor protein) of human cells that prevents their entry into the carcinogenesis-committed routeway.
Pin1
controls the ready (low energy change) equilibrium between the cis and trans distinctive folding configurations differentially at a proline residue: this amino acid residue in proteins is unique in bending sharply its peptide chain (to 90 degrees change): in the cis rather than trans orientation with respect to the peptide bond to residue X "upstream" linked as XCONHR. Moreover
p53 protein
can arrest a cell cycle progression (or trigger apoptosis) by acting as a transcription factor to nuclear DNA acting at
p53
nuclear responsive element controlling a larger number of genes that produce proteins that stop cell growth or stimulate apoptosis, in stressed cells. Oxidative stress by reactive oxygen species (ROS) is carcinogenic but also stops cell growth and triggers apoptosis, Cu-SOD removes ROS (see figure). Could superoxide dismutase (Cu-SOD), therefore, provide the DNA-damage direct second route (first route is binding of
Pin1
) in DNA-damaged cells to
p53
activation? The
p53 protein
that prevents carcinogenesis is activated by
Pin1
. In addition, this
p53
tumour suppressor protein is activated by Cu-SOD.
...
PMID:p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzyme. 1589 13
Tumor suppression by the
p53 protein
largely depends on the elimination of damaged cells by apoptosis. Mutations in the polyproline region (PPR) of
p53
impair its apoptotic function. Deletion of the PPR renders
p53
more sensitive to inhibition by Mdm2 via an unknown mechanism. We have explored the mechanism by which the PPR modulates the
p53
/Mdm2 loop. Proline 82 of
p53
was identified to be essential for its interaction with the checkpoint kinase 2 (Chk2) and consequent phosphorylation of
p53
on serine 20, following DNA damage. These physical and functional interactions are regulated by
Pin1
through cis-trans isomerization of proline 82. Our study unravels the pathway by which
Pin1
activates
p53
in response to DNA damage and explains how
Pin1
protects
p53
from Mdm2. Further, we propose a role for
Pin1
-dependent induction of
p53
conformational change as a mechanism responsible for the enhanced interaction between
p53
and Chk2 following DNA damage. Importantly, our findings elucidate the selection for mutations in the
Pin1
target Thr81/Pro82 motif within the PPR of
p53
in human cancer.
...
PMID:Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. 1596 95
The activation of the activating protein-1 (AP-1) family of transcription factors, including c-Fos and c-Jun family members, is one of the earliest nuclear events induced by growth factors that stimulate extracellular signal-regulated kinases (ERKs). In the case of c-Fos, the activation of ERK leads to an increased expression of c-fos mRNA. In turn, we have recently shown that ERK phosphorylates multiple residues within the carboxylterminal transactivation domain (TAD) of c-Fos, thus resulting in its increased transcriptional activity. However, how ERK-dependent phosphorylation regulates c-Fos function is still poorly understood. In this regard, it has been recently observed that the prolyl isomerase
Pin1
can interact with proteins phosphorylated on serine or threonine residues that precede prolines (pS/T-P), such as the transcription factors
p53
and c-Jun, thereby controlling their activity by promoting the cis-trans isomerization of these pS/T-P bonds. Here, we found that
Pin1
binds c-Fos through specific pS/T-P sites within the c-Fos TAD, and that this interaction results in an enhanced transcriptional response of c-Fos to polypeptide growth factors that stimulate ERK. Our findings suggest that c-Fos represents a novel target for the isomerizing activity of
Pin1
and support a role for
Pin1
in the mechanism by which c-Jun and c-Fos can cooperate to regulate AP-1-dependent gene transcription upon phosphorylation by mitogen-activated kinase (MAPK) family members.
...
PMID:Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. 1612 44
During the G0/G1-S phase transition, the timely synthesis and degradation of key regulatory proteins is required for normal cell cycle progression. Two of these proteins, c-Myc and cyclin E, are recognized by the Cdc4 E3 ligase of the Skp1/Cul1/Rbx1 (SCF) complex. SCF(Cdc4) binds to a similar phosphodegron sequence in c-Myc and cyclin E proteins resulting in ubiquitylation and degradation of both proteins via the 26 S proteosome. Since the prolyl isomerase
Pin1
binds the c-Myc phosphodegron and participates in regulation of c-Myc turnover, we hypothesized that
Pin1
would bind to and regulate cyclin E turnover in a similar manner. Here we show that
Pin1
regulates the turnover of cyclin E in mouse embryo fibroblasts.
Pin1
binds to the cyclin E-Cdk2 complex in a manner that depends on Ser384 of cyclin E, which is phosphorylated by Cdk2. The absence of
Pin1
results in an increased steady-state level of cyclin E and stalling of the cells in the G1/S phase of the cell cycle. The cellular changes that result from the loss of
Pin1
predispose
Pin1
null mouse embryo fibroblasts to undergo more rapid genomic instability when immortalized by conditional inactivation of
p53
and sensitizes these cells to more aggressive Ras-dependent transformation and tumorigenesis.
...
PMID:The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. 1622 25
Ataxia-telangiectasia mutated (ATM), the protein defective in ataxia-telangiectasia, plays a central role in DNA damage response and signaling to cell cycle checkpoints. We describe here a cell line from a patient with an ataxia-telangiectasia-like clinical phenotype defective in the
p53
response to radiation but with normal ATM activation and efficient downstream phosphorylation of other ATM substrates. No mutations were detected in ATM cDNA. A normal level of interaction between
p53
and peptidyl-prolyl-isomerase
Pin1
suggests that posttranslational modification was intact in these cells but operating at reduced level. Defective
p53
stabilization was accompanied by defective induction of
p53
effector genes and failure to induce apoptosis in response to DNA-damaging agents. Continued association between
p53
and murine double minute-2 (Mdm2) occurred in irradiated ATL2ABR cells in response to DNA damage, and incubation with Mdm2 antagonists, nutlins, increased the stabilization of
p53
and its transcriptional activity but failed to induce apoptosis. These results suggest that ATM-dependent stabilization of
p53
and induction of apoptosis by radiation involve an additional factor(s) that is defective in ATL2ABR cells.
...
PMID:Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype. 1654 Jun 36
Four sets of
p53
-binding proteins are discussed in this review. These are the E2F family, the ASPP family, Y-box-binding protein YB1, and the prolyl isomerase
Pin1
. Each appears to play a role in the decision by
p53
to induce an arrest of cell proliferation or apoptosis and they may also be independent markers of cancer. Their activities appear to be linked with the cell cycle and they may also interact with each other. In this review, the properties of each protein class are discussed as well as how they affect
p53
functions. A model is proposed as to how their activities might be coordinated.
...
PMID:Some p53-binding proteins that can function as arbiters of life and death. 1657 4
The stability and activity of
tumor suppressor p53
are tightly regulated and partially depend on the
p53
proline-rich domain (PRD). We recently analyzed mice expressing
p53
with a deletion of the PRD (
p53
(DeltaP)).
p53
(DeltaP), a weak transactivator hypersensitive to Mdm2-mediated degradation, is unable to suppress oncogene-induced tumors. This phenotype could result from the loss of two motifs:
Pin1
sites proposed to influence
p53
stabilization and PXXP motifs proposed to mediate protein interactions. We investigated the importance of these motifs by generating mice encoding point mutations in the PRD.
p53
(TTAA) contains mutations suppressing all putative
Pin1
sites in the PRD, while
p53
(AXXA) lacks PXXP motifs but retains one intact
Pin1
site. Both mutant proteins accumulated in response to DNA damage, although the accumulation of
p53
(TTAA) was partially impaired. Importantly,
p53
(TTAA) and
p53
(AXXA) are efficient transactivators and potent suppressors of oncogene-induced tumors. Thus,
Pin1
sites in the PRD may modulate
p53
stability but do not significantly affect function. In addition, PXXP motifs are not essential, but structure dictated by the presence of prolines, PXXXXP motifs that may mediate protein interactions, and/or the length of this region appears to be functionally significant. These results may explain why the sequence of the
p53
PRD is so variable in evolution.
...
PMID:Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression. 1715 31
Tumor suppressor p53
is essential for checkpoint control in response to a variety of genotoxic stresses. DNA damage leads to phosphorylation on the Ser/Thr-Pro motifs of
p53
, which facilitates interaction with
Pin1
, a pSer/pThr-Pro-specific peptidyl prolyl isomerase.
Pin1
is required for the timely activation of
p53
, resulting in apoptosis or cell cycle arrest. To investigate the physiological relationship between
Pin1
and
p53
, we created
Pin1
-/-
p53
-/- mice. These
p53
-deficient mice spontaneously developed lymphomas, mainly of thymic origin, as well as generalized lymphoma infiltration into other organs, including the liver, kidneys and lungs. Ablation of
Pin1
, in addition to
p53
, accelerated the thymic hyperplasia, but the thymocytes in these
Pin1
-/-
p53
-/- mice did not infiltrate other organs. The thymocytes in 12-week-old
Pin1
-/-
p53
-/- mice were CD4(-)CD8(-) (double negative) and had significantly higher levels of the intracellular form of Notch1 (NIC) than the thymocytes of
p53
-/- or wild-type mice. Presenilin-1, a cleavage enzyme for NIC generation from full-length Notch1 was increased in the thymocytes of
Pin1
-/-
p53
-/- mice.
Pin1
depletion also inhibited the degradation of NIC by proteasomes. These results suggest that both
Pin1
and
p53
control the normal proliferation and differentiation of thymocytes by regulating the NIC level.
...
PMID:Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. 1716 15
We have previously demonstrated that DNA damage leads to stabilization and accumulation of Che-1, an RNA polymerase II-binding protein that plays an important role in transcriptional activation of
p53
and in maintenance of the G(2)/M checkpoint. Here we show that Che-1 is down-regulated during the apoptotic process. We found that the E3 ligase HMD2 physically and functionally interacts with Che-1 and promotes its degradation via the ubiquitin-dependent proteasomal system. Furthermore, we found that in response to apoptotic stimuli Che-1 interacts with the peptidyl-prolyl isomerase
Pin1
and that conformational changes generated by
Pin1
are required for Che-1/HDM2 interaction. Notably, a Che-1 mutant lacking the capacity to bind
Pin1
exhibits an increased half-life and this correlates with a diminished apoptosis in response to genotoxic stress. Our results establish Che-1 as a new
Pin1
and HDM2 target and confirm its important role in the cellular response to DNA damage.
...
PMID:The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage. 1746 7
<< Previous
1
2
3
4
5
6
7
Next >>